Simply Solventless Concentrates Ltd. Stock
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0400 CAD | 0.00% |
|
0.00% | -71.43% |
| 06-19 | Simply Solventless Expects to File Financial Statements by July 3 | MT |
| 04-30 | Simply Solventless Concentrates Ltd. Appoints William Macdonald as Interim Chief Financial Officer | CI |
| Market Cap | 16.17M 11.41M 10M 9.23M 8.62M 1.08B 16.32M 110M 42.61M 531M 42.88M 41.95M 1.84B | P/E 2023 |
7.5x | P/E 2024 | -10x |
|---|---|---|---|---|---|
| Enterprise Value | 25.27M 17.83M 15.62M 14.42M 13.47M 1.69B 25.5M 172M 66.59M 829M 67.02M 65.56M 2.88B | EV / Sales 2023 |
1.44x | EV / Sales 2024 | 6.8x |
| Free-Float |
81.55% | Yield 2023 * |
-
| Yield 2024 | - |
| 3 months | -38.46% | ||
| 6 months | -63.64% | ||
| Current year | -71.43% |
| 1 week | 0.04 |  | 0.04 |
| 1 month | 0.04 | | 0.05 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.4 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-10 | Buy | Director | 5,000 | 0.0052% | ||
| 02-10 | Buy | Director | 9,500 | 0.0098% | ||
| 02-10 | Buy | Director | 5,500 | 0.0057% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -80.00% | -84.62% | 3.26M | |
| +0.47% | -3.83% | -11.58% | -7.05% | 12.77B | |
| +0.21% | -5.61% | -34.57% | -56.61% | 4.76B | |
| -0.83% | -10.26% | -13.37% | -4.03% | 4.34B | |
| -0.13% | -1.33% | +15.71% | -15.38% | 3.8B | |
| +0.20% | -4.20% | +8.20% | -41.30% | 3.71B | |
| -0.66% | -5.05% | -5.99% | -8.95% | 3.53B | |
| -2.84% | -5.00% | -11.68% | -3.05% | 3.11B | |
| -1.11% | -0.72% | -5.15% | -25.12% | 2.38B | |
| -0.94% | -4.32% | -12.63% | +31.12% | 1.67B | |
| Average | -0.56% | -4.19% | -15.10% | -21.50% | 4.01B | |
| Weighted average by Cap. | -0.29% | -4.36% | -9.27% | -15.91% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 6.19M 4.37M 3.83M 3.53M 3.3M 414M 6.25M 42.03M 16.32M 203M 16.42M 16.06M 706M | 13.68M 9.65M 8.46M 7.8M 7.29M 914M 13.8M 92.85M 36.05M 449M 36.28M 35.49M 1.56B |
| Net income | 1.04M 734K 643K 594K 555K 69.51M 1.05M 7.06M 2.74M 34.14M 2.76M 2.7M 119M | -5.19M -3.67M -3.21M -2.96M -2.77M -347M -5.24M -35.26M -13.69M -170M -13.78M -13.48M -592M |
| Net Debt | 1.63M 1.15M 1.01M 929K 868K 109M 1.64M 11.06M 4.29M 53.44M 4.32M 4.23M 186M | 9.1M 6.42M 5.63M 5.19M 4.85M 608M 9.18M 61.77M 23.98M 299M 24.13M 23.61M 1.04B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/06/26 | 0.0400 $ | 0.00% | 337,243 |
| 19/06/26 | 0.0400 $ | +14.29% | 281,822 |
| 18/06/26 | 0.0350 $ | -12.50% | 242,300 |
| 17/06/26 | 0.0400 $ | 0.00% | 349,855 |
| 16/06/26 | 0.0400 $ | +14.29% | 269,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
